| 0 (0%) | 11-11 17:42 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 36.99 | 1-year : | 45.19 |
| Resists | First : | 31.67 | Second : | 38.69 |
| Pivot price | 28.08 |
|||
| Supports | First : | 20.31 | Second : | 16.9 |
| MAs | MA(5) : | 23.12 |
MA(20) : | 29.69 |
| MA(100) : | 20.44  |
MA(250) : | 14.13 |
|
| MACD | MACD : | -1.3 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 21.3 |
D(3) : | 17.2 |
| RSI | RSI(14): 42.6 |
|||
| 52-week | High : | 38.69 | Low : | 5.34 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ STOK ] has closed above bottom band by 31.9%. Bollinger Bands are 175.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 25.16 - 25.34 | 25.34 - 25.48 |
| Low: | 21.52 - 21.68 | 21.68 - 21.81 |
| Close: | 24.86 - 25.16 | 25.16 - 25.38 |
Mon, 10 Nov 2025
(STOK) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Mon, 10 Nov 2025
Wrexham fan views: Is the Stok Cae Ras enough of a 'fortress' to bring promotion? - BBC
Mon, 10 Nov 2025
Stoke Therapeutics (STOK) Is Down 23.9% After Reporting Sharp Nine-Month Profit Turnaround and Revenue Surge - simplywall.st
Sat, 08 Nov 2025
Stoke Therapeutics (STOK): Valuation Insights After Q3 Sales Surge and Return to Profitability - simplywall.st
Sat, 08 Nov 2025
How to recover losses in STOK stock - July 2025 Patterns & AI Forecast Swing Trade Picks - newser.com
Sat, 08 Nov 2025
Cantor Fitzgerald Issues Negative Estimate for STOK Earnings - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 55 (M) |
| Shares Float | 38 (M) |
| Held by Insiders | 4.3 (%) |
| Held by Institutions | 119.3 (%) |
| Shares Short | 10,830 (K) |
| Shares Short P.Month | 11,390 (K) |
| EPS | 0.87 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.11 |
| Profit Margin | 26.2 % |
| Operating Margin | -197.6 % |
| Return on Assets (ttm) | 7.2 % |
| Return on Equity (ttm) | 18.1 % |
| Qtrly Rev. Growth | 186 % |
| Gross Profit (p.s.) | 3.64 |
| Sales Per Share | 3.64 |
| EBITDA (p.s.) | 0.77 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 62 (M) |
| Levered Free Cash Flow | 43 (M) |
| PE Ratio | 28.86 |
| PEG Ratio | 0 |
| Price to Book value | 4.1 |
| Price to Sales | 6.88 |
| Price to Cash Flow | 22.33 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|